Development of a sensitive enzyme-linked immunosorbent assay for measurement of DNase I in human serum

Clinica Chimica Acta

Volumn 403, Issue 1-2, 2009, Pages 219-222

  Nakajima, Tamiko ^a   Takagi, Rie ^a   Tajima, Yutaka ^a   Makita, Chikako ^a   Kominato, Yoshihiko ^a   Kuribara, Jun ^b   Ohshima, Shigeru ^b   Tada, Hiroshi ^c   Tsurugaya, Hideki ^b   Kobayashi, Yasuyuki ^b   Takeshita, Haruo ^d   Kawai, Yasuyuki ^e   Yasuda, Toshihiro ^f  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA PREFECTURAL CARDIOVASCULAR CENTER   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^e KANAZAWA MEDICAL UNIVERSITY   (Japan)

^f UNIVERSITY OF FUKUI   (Japan)

Author keywords

Acute myocardial infarction; Deoxyribonuclease I; Diagnostic marker; ELISA

Indexed keywords

DEOXYRIBONUCLEASE I; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADULT; ANTIBODIES; ANTIBODY SPECIFICITY; DEOXYRIBONUCLEASE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 64849084930     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.03.005     Document Type: Article

References (20)

1. Moore S. Pancreatic DNase. In: Boyer P.D. (Ed). The enzymes vol. 14 (1981), Academic Press, New York 281-296
2. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., and Möröy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nature Genet 25 (2000) 177-181
3. Kumamoto T., Kawai Y., Arakawa K., et al. Association of Gln222Arg polymorphism in the deoxyribonuclease I (DNase I) gene with myocardial infarction in Japanese patients. Eur Heart J 27 (2006) 2081-2087
4. Kawai Y., Yoshida M., Arakawa K., et al. Diagnostic use of serum deoxyribonuclease I activity as a novel early-phase marker in acute myocardial infarction. Circulation 109 (2004) 2398-2400
5. Arakawa K., Kawai Y., Kumamoto T., et al. Serum deoxyribonuclease I activity can be used as a sensitive marker for detection of transient myocardial ischemia induced by percutaneous coronary intervention. Eur Heart J 26 (2005) 2375-2380
6. Morikawa N., Kawai Y., Arakawa K., et al. Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test. Eur Heart J 28 (2007) 2992-2997
7. Sinicropi D.V., and Lazarus R.A. Assays for human DNase I activity in biological samples. In: Schein C.H. (Ed). Nuclease methods and protocols (2001), Humana Press Inc, Totowa, New Jersey 325-333
8. Nadano D., Yasuda T., and Kishi K. Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme diffusion method. Clin Chem 39 (1993) 448-452
9. Ulmer J.S., Herzka A., Toy K.J., et al. Engineering actin-resistant human DNase I for treatment of cystic fibrosis. Proc Natl Acad Sci USA 93 (1996) 8225-8229
10. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
11. Takeshita H., Yasuda T., Nakazato E., et al. Use of human recombinant DNase I expressed in Cos-7 cells as an immunogen to produce a specific anti-DNase I antibody. Exp Clin Immunogenet 18 (2001) 226-232
12. Nakajima T., Yasuda T., Takeshita H., et al. Rapid purification of human DNase I using mouse monoclonal anti-DNase I antibodies and characterization of the antibodies. Exp Clin Immunogenet 17 (2000) 71-76
13. Engbaek F. A general procedure for optimizing concentrations of capture antibody, biotinylated detecting antibody, and enzyme-labeled avidin in ELISAs-application to assays for α-fetoprotein, prolactin, FSH and LH in serum. J Clin Immunoassay 17 (1994) 151-159
14. Takeshita H., Nakajima T., Mogi K., et al. Rapid quantification of DNase I activity in one-microliter serum samples. Clin Chem 50 (2003) 446-448
15. Sinha M.K., Gaze D.C., Tippins J.R., Collinson P.O., and Kaski J.C. Ischemia modified albumin is sensitive marker of cardial ischemia after percutaneous coronary intervention. Circulation 107 (2003) 2403-2405
16. Borderie D., Allanore Y., Meune C., Devaux J.Y., Ekindjian O.G., and Kahan K. A high ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 50 (2004) 2190-2193
17. Yasuda T., Takeshita H., Ueki M., et al. Tissue-specific in vivo inhibition of DNase I gene expression by somatostatin. Biochem Biophys Res Commun 283 (2001) 287-291
18. Napirei M., Ricken A., Eulitz D., Knoop H., and Mannherz H.G. Expression pattern of the deoxyribonuclease I gene: lessons from the Dnase1 knockout mouse. Biochem J 380 (2004) 929-937
19. Kominato Y., Ueki M., Iida R., et al. Characterization of human deoxyribonuclease I gene (DNASE1) promoters reveals utilization of two transcription-starting exons and involvement of Sp1 in its transcriptional regulation. FEBS J 273 (2006) 3094-3105
20. Kominato Y., Iida R., Nakajima T., et al. Hypoxia induces upregulation of the deoxyribonuclease I gene in the human pancreatic cancer cell line QGP-1. Biochem Biophis Acta 1770 (2007) 1567-1575